• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Todd Steffes Explains How Predictive Modeling Can Reduce the Cost of Patient Non-Adherence

Article

Todd Steffes, Vice President, Healthcare Practice, FICO, explains how predictive modeling on medication adherence translates to better value and resource allocation in an industry where nonadherence costs more than $300 billion.

Mr. Steffes discusses how this decision-management company utilizes its own predictive analytic technology combined with third-party public data to evaluate an individual's medication adherence history over the period of 1 year. The data are then used to help healthcare stakeholders more efficienty utilize their resource allocation, spending more upfront time with at-risk patients and less with patients known to take their medicines as prescribed.

Related Videos
Debra Boyer, MD, MHPE, ATSF.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Plasminogen is vital in the body's coagulation process and breaking down clots | image credit: peterschreiber.media - stock.adobe.com
ISPOR 2024 Recap
Chris Pagnani, MD, PC
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Michael Morse, MD, Duke Cancer Center
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.